Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509613
Status:
COMPLETED
Last Update Posted:
2009-09-18
First Post:
2007-07-30
Brief Title:
Phase 1 Study With Sorafenib and Sirolimus
Sponsor:
Radboud University Medical Center
Organization:
Radboud University Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory to Standard Therapies |
| Advanced Solid Tumor |
Keywords: